Senticell
Senticell is developing a liquid-biopsy diagnostic based on nucleic acids associated with red blood cells.
$7MSeed
ParticipantCF
Capital Factory
Activity from announced rounds
Activity in this selectionOct 16, 2026 · Jul 19, 2026
Capital Factory is a Texas venture ecosystem and investment manager named by Senticell and Artis.
Recorded funding activity
Senticell develops a liquid-biopsy diagnostic using nucleic acids associated with red blood cells. Artis manages digital presence for architecture and home-building businesses, while Casimir develops semiconductor-based power technology. These covered companies have distinct products and development risks.
- Rounds participated in
- 1
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $7M 1 disclosed · full round size, not this investor’s share